C O N T R A C T   A N A L Y S I S

Alfatestlab: cGMP analytical testing services for material characterization… but not only!

At ALFATESTLAB we are experts in analytical techniques for material characterization: solid state, liquid dispersions, LNPs, polymers, etc. We are available to support you on batch release analysis, analytical method development, validation and transfer, R&D analytical studies, industrial trouble-shooting, or advanced training on analytical techniques available in our laboratory.

Our support also include​​​​​​​s nanomedicine services such as method development for LNPs microfluidic production, EVs extracellular vesicles characterization and much more!

AlfatestLab is GMP certified by AIFA - Download GMP certification

cGMP services at Alfatestlab include:

  • Particle size analysis with laser diffraction technique of powders, liquid dispersions, sprays and aerosols
  • Particle size, shape and chemical identification in powder mixtures, liquid dispersions, creams etc. using Morphologically Directed Raman Spectroscopy MDRS  technique
  • Nanosystems characterization by Dynamic Light Scattering analysis and Zeta potential
  • BET Surface area and porosity
  • DSC Thermal analysis

Visit our website for a complete overview of our services including ISO17025 accredited techniques.

info@alfatestlab.com | +39 02 6129 4602 | www.alfatestlab.com

Meet us @CPHI in Milan booth C5138 Manufacturing & Services zone

Go to article: Home | Enhancing therapy adherence with prodrugsGo to article: Editor's letterGo to article: ContentsGo to article: Mimotopes Company InsightGo to article: MimotopesGo to article: CytivaGo to article: NiproGo to article: Laboratorios Argenol Company InsightGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Project UpdatesGo to article: Avenga Company InsightGo to article: Lactalis IngredientsGo to article: BSP PharmaceuticalsGo to article: AlfatestLABGo to article: Alphial Company InsightGo to article: In DepthGo to article: Prodrugs and patents: Enhancing therapy adherence and reducing side effectsGo to article: Are PBMs to blame for high drug prices in the US?Go to article: Into the unknown: how quickly can vaccines be developed for Disease XGo to article: US negotiations for first round of drugs reveal $6bn in Medicare savings Go to article: Emerging microbiome market – unlocking new frontiers Go to article: Build or buy? Key considerations for in-house manufacturingGo to article: BiomeBank Company InsightGo to article: IMP Pharmaceutical ServicesGo to article: XylemGo to article: Sponsored SupplementsGo to article: Techniconsult Firenze Company InsightGo to article: PfanstiehlGo to article: Duoject Medical Systems Company InsightGo to article: ListingsGo to article: EventsGo to article: Excellence AwardsGo to article: Innovation RankingsGo to article: Buyer's GuidesGo to article: Zenatek Company InsightGo to article: BEA TechnologiesGo to article: Next issue